Mucocutaneous manifestations of viral diseases

  title={Mucocutaneous manifestations of viral diseases},
  author={Paul M. Benson},
  journal={Journal of The American Academy of Dermatology},
  • P. Benson
  • Published 1 July 2004
  • Medicine, Education
  • Journal of The American Academy of Dermatology
8 Citations

Varicella zoster: an update on current treatment options and future perspectives

Starting treatment with gabapentin and antiviral concomitantly as soon as the rash develops may reduce the severity of complications but there is a lack of data showing these medications preventing the development of PHN.

Therapeutic options for herpes labialis: experimental and natural therapies.

Experimental and natural treatments that are available for herpes labialis and its associated symptoms are reviewed in this final part of the series.

Profil penyakit infeksi kulit karena virus pada anak di Divisi Dermatologi Anak Poliklinik Ilmu Kesehatan Kulit dan Kelamin RSUP Prof. Dr. R. D. Kandou Manado periode tahun 2013 - 2015

Skin viral diseases in children were found in 12.71% of new patients, most common in females and aged 5-14 years, and was the most common skin viral disease in all ages.

HPV Carcinomas in Immunocompromised Patients

This review will discuss anogenital lesions in immunocompromised patients, cutaneous warts at nongenital sites, the association of HPV with skin cancer in immunosuppressed patients, warts and carcinomas in organ-transplant patients, HIV-positive patients with HPV infections, and the management of cutaneous disease in the immunocombromised patient.

Prevalence and distribution of Human Papillomavirus (HPV) genotypes among HIV infected women in Lomé, Togo

This study showed the diversity of circulating HPV genotypes in Togo and programs of HPV vaccination and early detection of benign or precancerous lesions should be implemented to reduce cancer-related comorbidities.

Epstein-Barr Virus Infection of Langerhans Cell Precursors as a Mechanism of Oral Epithelial Entry, Persistence, and Reactivation

The first evidence demonstrating that EBV latently infects a unique subset of blood-borne mononuclear cells that are direct precursors to Langerhans cells is presented, which forms the basis of a proposed new model of EBV transition from blood to oral epithelium.

[Ebola: characterization, history and cutaneous manifestations].

Ebola virus (EV) is one of the most virulent human pathogens and the transmission to humans is across wild animals (especially primates) and the propagation in human populations is through bodily fluid contact.

Syndromal tropical dermatology